Trial intelligence / Profile preview

Opioid-free TIVA versus volatile-opioid anesthesia for bariatric surgery

ACTRN12620000198921Phase 3Recruiting

Sponsor
Department of Anaesthesia
Start
Nov 2020
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of dexmedetomidine, ketamine, lidocaine, propofol, desflurane and 2 more in obesity (2 arms), sponsored by Department of Anaesthesia. Primary endpoint: Postoperative opioid requirement. Started Nov 2020; status: recruiting.

02

Drugs

dexmedetomidineketaminelidocainepropofoldesflurane
03

Conditions

obesity

Beyond the preview

Go deeper on ACTRN12620000198921.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12620000198921.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call